Molecular characterization of plasmacytoid urothelial carcinoma and the impact on treatment implications
Authors:
Open Access
- 17 November 2023
- journal article
- research article
- Published by Elsevier in Cancer Treatment and Research Communications
- Vol. 37, 100779
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (T32-CA244125)
- National Cancer Institute (1K08CA248967-01)
This publication has 49 references indexed in Scilit:
- Plasmacytoid Bladder Cancer: Variant Histology With Aggressive Behavior and a New Mode of Invasion Along Fascial PlanesUrology, 2014
- The Cancer Genome Atlas Pan-Cancer analysis projectNature Genetics, 2013
- Nuclear E-cadherin Expression is Associated with the Loss of Membranous E-cadherin, Plasmacytoid Differentiation and Reduced Overall Survival in Urothelial Carcinoma of the BladderAnnals of Surgical Oncology, 2012
- Plasmacytoid Carcinoma of the Bladder: A Urothelial Carcinoma Variant With a Predilection for Intraperitoneal SpreadJournal of Urology, 2012
- Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladderNature Genetics, 2011
- The plasmacytoid carcinoma of the bladder—rare variant of aggressive urothelial carcinomaInternational Journal of Cancer, 2010
- Role of syndecan‐1 (CD138) in cell survival of human urothelial carcinomaCancer Science, 2009
- Plasmacytoid urothelial carcinoma of the urinary bladder: A case report and immunohistochemical studyPathology - Research and Practice, 2009
- Urothelial carcinoma with plasmacytoid variants producing both human chorionic gonadotropin and carbohydrate antigen 19-9Urology, 2006
- Transformation of cell adhesion properties by exogenously introduced E-cadherin cDNANature, 1987